Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 13, Issue 6, Pages 132
Publisher
MDPI AG
Online
2020-06-25
DOI
10.3390/ph13060132
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
- (2020) Yushun Wan et al. JOURNAL OF VIROLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
- (2020) Nature Microbiology
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Drug repositioning is an alternative for the treatment of coronavirus COVID-19
- (2020) Marissa B. Serafin et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Natural products may interfere with SARS-CoV-2 attachment to the host cell
- (2020) Abdo A. Elfiky JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- COVID-19 spike-host cell receptor GRP78 binding site prediction
- (2020) Ibrahim M. Ibrahim et al. JOURNAL OF INFECTION
- Is the Rigidity of SARS-CoV-2 Spike Receptor-Binding Motif the Hallmark for Its Enhanced Infectivity? Insights from All-Atoms Simulations
- (2020) Angelo Spinello et al. Journal of Physical Chemistry Letters
- Structural basis of receptor recognition by SARS-CoV-2
- (2020) Jian Shang et al. NATURE
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Origin, Potential Therapeutic Targets and Treatment for Coronavirus Disease (COVID-19)
- (2020) Muhammad Shahid Nadeem et al. Pathogens
- Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- (2020) Mandeep R Mehra et al. LANCET
- COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses
- (2020) Muhammad Adnan Shereen et al. Journal of Advanced Research
- Neratinib in HER2-Positive Breast Cancer Patients
- (2019) Rutugandha Paranjpe et al. ANNALS OF PHARMACOTHERAPY
- Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies
- (2019) Fiona H Tan et al. OncoTargets and Therapy
- Coronavirus envelope protein: current knowledge
- (2019) Dewald Schoeman et al. Virology Journal
- GRP78: A cell's response to stress
- (2019) Ibrahim M. Ibrahim et al. LIFE SCIENCES
- Systemic release of heat-shock protein 27 and 70 following severe trauma
- (2019) Thomas Haider et al. Scientific Reports
- Unfolded Protein Response in Acute Respiratory Distress Syndrome
- (2019) Nektarios Barabutis LUNG
- The Circulating GRP78/BiP Is a Marker of Metabolic Diseases and Atherosclerosis: Bringing Endoplasmic Reticulum Stress into the Clinical Scenario
- (2019) Josefa Girona et al. Journal of Clinical Medicine
- Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models
- (2019) Simon P. Langdon et al. Scientific Reports
- Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report
- (2019) Le-Tian Huang et al. Frontiers in Oncology
- Glucose-regulated protein 78 substrate-binding domain alters its conformation upon EGCG inhibitor binding to nucleotide-binding domain: Molecular dynamics studies
- (2018) K. R. D. Sagara N. S. Gurusinghe et al. Scientific Reports
- GRP78 Is an Important Host Factor for Japanese Encephalitis Virus Entry and Replication in Mammalian Cells
- (2017) Minu Nain et al. JOURNAL OF VIROLOGY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Targeting HSP70 and GRP78 in canine osteosarcoma cells in combination with doxorubicin chemotherapy
- (2016) Jonathan Asling et al. CELL STRESS & CHAPERONES
- Probing the ATP Site of GRP78 with Nucleotide Triphosphate Analogs
- (2016) Scott J. Hughes et al. PLoS One
- Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
- (2015) Caroline V.M. Verhagen et al. RADIOTHERAPY AND ONCOLOGY
- Close and Allosteric Opening of the Polypeptide-Binding Site in a Human Hsp70 Chaperone BiP
- (2015) Jiao Yang et al. STRUCTURE
- Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Julie Dyall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HSPA5 is an essential host factor for Ebola virus infection
- (2014) St. Patrick Reid et al. ANTIVIRAL RESEARCH
- Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling
- (2014) Neng Wang et al. CARCINOGENESIS
- GRP78 is a novel receptor initiating a vascular barrier protective response to oxidized phospholipids
- (2014) Anna A. Birukova et al. MOLECULAR BIOLOGY OF THE CELL
- HKH40A downregulates GRP78/BiP expression in cancer cells
- (2014) T Kosakowska-Cholody et al. Cell Death & Disease
- Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78
- (2013) S Martin et al. BRITISH JOURNAL OF CANCER
- Danusertib, an aurora kinase inhibitor
- (2012) Hielke J Meulenbeld et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Adenosine-Derived Inhibitors of 78 kDa Glucose Regulated Protein (Grp78) ATPase: Insights into Isoform Selectivity
- (2011) Alba T. Macias et al. JOURNAL OF MEDICINAL CHEMISTRY
- Japanese encephalitis virus co-opts the ER-stress response protein GRP78 for viral infectivity
- (2011) Yi-Ping Wu et al. Virology Journal
- Cell Surface Relocalization of the Endoplasmic Reticulum Chaperone and Unfolded Protein Response Regulator GRP78/BiP
- (2010) Yi Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
- (2008) Rupert Langer et al. BMC CANCER
- Medicinal Chemistry and the Molecular Operating Environment (MOE): Application of QSAR and Molecular Docking to Drug Discovery
- (2008) Santiago Vilar et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now